TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin

This publication has 26 references indexed in Scilit:

• Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma
  International Journal of Cancer, 2008
• Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis
  Oncogene, 2007
• Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP
  Oncogene, 2007
• Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells
  Biochemical and Biophysical Research Communications, 2007
• Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells
  Carcinogenesis: Integrative Cancer Research, 2007
• Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis
  Molecular Cancer Therapeutics, 2006
• Promoting apoptosis as a strategy for cancer drug discovery
  Nature Reviews Cancer, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells
  JNCI Journal of the National Cancer Institute, 2004
• Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway
  Journal of Biological Chemistry, 2000